Picture of ADMA Biologics logo

ADMA ADMA Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Brief: Adma Biologics Announces Second Quarter 2022 Financial Results And Provides Business Update

Aug 10 (Reuters) - ADMA Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS ANNOUNCES SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * Q2 REVENUE ROSE 90 PERCENT TO $33.9 MILLION
    * FULL YEAR 2022 TOTAL REVENUES EXPECTED TO EXCEED $130
MILLION
    * CONTINUES TO ANTICIPATE GENERATING APPROXIMATELY $250
MILLION OR
MORE IN TOPLINE REVENUE IN 2024
    * QTRLY LOSS PER SHARE $0.07

Source text for Eikon:  ID:nGNX1NvMKf 
Further company coverage:  ADMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ADMA Biologics

See all news